1-(2-bromo-5-chlorophenyl)-2-(2-chloroethyl)-7-methylbenzimidazole
C16H13BrCl2N2 — CID 115553755
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2-bromo-5-chlorophenyl)-2-(2-chloroethyl)-7-methylbenzimidazole
1-(2-bromo-5-chlorophenyl)-2-(2-chloroethyl)-7-methylbenzimidazole (PubChem CID 115553755) has the molecular formula C16H13BrCl2N2 and a molecular weight of 384.10 g/mol. Its IUPAC name is 1-(2-bromo-5-chlorophenyl)-2-(2-chloroethyl)-7-methylbenzimidazole.
Molecular Properties
| Compound Name | 1-(2-bromo-5-chlorophenyl)-2-(2-chloroethyl)-7-methylbenzimidazole |
|---|---|
| PubChem CID | 115553755 |
| Molecular Formula | C16H13BrCl2N2 |
| Molecular Weight | 384.10 g/mol |
| Exact Mass | 381.96 |
| IUPAC Name | 1-(2-bromo-5-chlorophenyl)-2-(2-chloroethyl)-7-methylbenzimidazole |
| SMILES | Cc1cccc2nc(CCCl)n(-c3cc(Cl)ccc3Br)c12 |
| InChI | InChI=1S/C16H13BrCl2N2/c1-10-3-2-4-13-16(10)21(15(20-13)7-8-18)14-9-11(19)5-6-12(14)17/h2-6,9H,7-8H2,1H3 |
| InChIKey | XPBFRKJOGFEILG-UHFFFAOYSA-N |
| XLogP | 5.53 |
| TPSA | 17.82 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 384.10 |
| LogP ≤ 5 | 5.53 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 115553755 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.